Insight journal - Company

Galderma: M&A activity 2005-2013

Posted on 27 January 2014

Galderma has announced 4 M&A deals since 2009, with the lead deals being the acquisition of Q-Med.

Abstracted from: Report: Partnering Agreements with Galderma 2009-2014

Galderma is involved in M&A activity for growth similar to its peers in the list of top pharmaceutical companies. Galderma has on occasions sought growth through strategic acquisition, for example when acquiring Q-Med, a well-established aesthetic medical devices company.

The following figure shows the level of Galderma M&A deal announcements since 2005.

Figure 1: Galderma M&A deals 2009-2014

G1M

 

Source: Current Agreements, 2014

Galderma has signed 4 M&A deals since 2009. The companies acquired include:

Spirig Pharma

Graceway Pharmaceuticals

Q-Med

Medion Diagnostics

View the full list at Current Agreements (subscription required)

Galderma has been attracted to acquisition transactions whereby the company expands through the acquisition and assimilation of strategic target assets and technologies to realize business growth. This is evidenced by the acquisition of Spirig Pharma to access products to treat solar damages and skin barrier function impairment.

The following figure provides a summary of the top M&A deals by headline value.

Figure 2: Top Galderma M&A deals by headline value 2009-2014

Figure 2: Top Galderma M&A deals by headline value 2009-2014

 

Source: Current Agreements, 2014

Our report provides more detailed insight into the details of each deal.

See: Partnering Agreements with Galderma 2009-2014

Galderma M&A at Current Agreements                                      

View all partnering deals for Galderma: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 

Full details on each deal can be found at CurrentAgreements (subscription required)

Or purchase report: Report: Partnering Agreements with Galderma 2009-2014

More

Summary profile data for Galderma

Partnering interests for Galderma

Partnering activity for Galderma

 

Available reports from Current Partnering

Report: Partnering Agreements with Galderma 2009-2014

Report: Top 50 Big Pharma Partnering and M&A Deal Trends

Report: Merger & Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics

 

Available resources for deal coverage for Galderma

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Galderma company profile, recent partnering, M&A and financing news and articles

 

Related

Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter – reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

 

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

 

Print Friendly, PDF & Email

Leave a Reply

 

cabannerad300x150new4gif
rauconbadgejpg
e78banner300x150animgif
cabannerad300x150new4gif
e79banner300x150gif
e78banner300x150animgif